Haleon Plc (HLNCF)
4.435
-0.12
(-2.74%)
USD |
OTCM |
Nov 17, 16:00
Haleon Price : 4.435 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 4.535 | 4.535 | 4.435 | 4.435 | 30132.00 |
| Nov 16, 2026 | 4.56 | 4.56 | 4.56 | 4.56 | 619.00 |
| Nov 13, 2026 | 4.565 | 4.70 | 4.555 | 4.555 | 173039.0 |
| Nov 12, 2026 | 4.505 | 4.65 | 4.505 | 4.65 | 2265.00 |
| Nov 11, 2026 | 4.51 | 4.63 | 4.494 | 4.52 | 12684.00 |
| Nov 10, 2026 | 4.484 | 4.50 | 4.479 | 4.50 | 6235.00 |
| Nov 09, 2026 | 4.495 | 4.495 | 4.495 | 4.495 | 312.00 |
| Nov 06, 2026 | 4.50 | 4.50 | 4.50 | 4.50 | 1649.00 |
| Nov 05, 2026 | 4.59 | 4.59 | 4.56 | 4.56 | 4679.00 |
| Nov 04, 2026 | 4.51 | 4.53 | 4.440 | 4.440 | 10658.00 |
| Nov 03, 2026 | 4.425 | 4.425 | 4.378 | 4.385 | 3130.00 |
| Nov 02, 2026 | 4.17 | 4.345 | 4.17 | 4.345 | 13755.00 |
| Oct 30, 2026 | 4.383 | 4.383 | 4.15 | 4.15 | 892.00 |
| Oct 29, 2026 | 4.225 | 4.23 | 4.17 | 4.23 | 24540.00 |
| Oct 28, 2026 | 5.005 | 5.005 | 5.005 | 5.005 | 0.000 |
| Oct 27, 2026 | 5.005 | 5.005 | 5.005 | 5.005 | 1048.00 |
| Oct 26, 2026 | 5.105 | 5.11 | 5.10 | 5.10 | 7140.00 |
| Oct 23, 2026 | 5.095 | 5.095 | 5.09 | 5.09 | 2928.00 |
| Oct 22, 2026 | 5.135 | 5.135 | 4.98 | 4.98 | 879.00 |
| Oct 21, 2026 | 5.19 | 5.19 | 5.19 | 5.19 | 502.00 |
| Oct 20, 2026 | 5.06 | 5.19 | 5.06 | 5.19 | 931.00 |
| Oct 19, 2026 | 4.85 | 4.975 | 4.85 | 4.96 | 2098.00 |
| Oct 16, 2026 | 4.81 | 4.980 | 4.81 | 4.95 | 17690.00 |
| Oct 15, 2026 | 4.95 | 4.95 | 4.891 | 4.891 | 4564.00 |
| Oct 14, 2026 | 4.85 | 4.85 | 4.85 | 4.85 | 32.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 182.27 |
| GSK Plc | 49.24 |
| Hikma Pharmaceuticals Plc | 23.58 |
| Allergy Therapeutics Plc | 0.15 |
| Shield Therapeutics Plc | 0.0413 |
Price Related Metrics
| PE Ratio | 18.24 |
| PS Ratio | 2.654 |
| PEG Ratio | 0.2879 |
| Price to Free Cash Flow | 15.09 |
| Earnings Yield | 5.48% |
| Market Cap | 38.91B |
| PEGY Ratio | 0.2781 |
| Operating PE Ratio | 11.39 |
| Normalized PE Ratio | 16.57 |